Peek behind the paper: solid lipid nanoparticles as potential non-viral vectors for CRISPR/Cas9 delivery


In this behind-the-paper interview, part of our ‘In Focus’ feature on functional nanomaterials in cancer therapy, to coincide with the recently published Nanomedicine Special Focus Issue on this topic, Hasan Akbaba (Ege University, Bornova, Turkey) discusses research exploring the use of solid lipid nanoparticles (SLNs) as non-viral vectors for CRISPR/Cas9 delivery. Read the full research paper, part of the Nanomedicine Special Focus Issue, here >>> Please could you introduce yourself, your organization and provide a brief overview of your career to date? I am currently an Assistant Professor in the Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, at Ege University. I...

To view this content, please register now for access

It's completely free